Measurable residual disease-driven therapy after radiotherapy for early-stage follicular lymphoma
Jillian R Gunther1, Chelsea C Pinnix1
1The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The Lancet. Haematology
|June 27, 2024
Abstract
No abstract available in PubMed .


